We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI-Driven Algorithm Uses fMRI Scans to Detect Autism and Predict Severity

By MedImaging International staff writers
Posted on 07 Apr 2022
Image: New AI-Driven algorithm can detect autism in brain “fingerprints” (Photo courtesy of Unsplash)
Image: New AI-Driven algorithm can detect autism in brain “fingerprints” (Photo courtesy of Unsplash)

Autism is one of the most common neurodevelopmental disorders but lacks objective biomarkers - telltale measurements that reveal a medical condition’s presence and sometimes severity -meaning there is no simple test for the disorder. Instead, diagnosis is based on observing patients’ behaviors, which are naturally highly variable and thus make diagnosis a challenge. Researchers have now developed an algorithm that may help discern if someone has autism by looking at brain scans.

The novel algorithm, developed by researchers at Stanford University (Stanford, CA, USA) and driven by recent advances in artificial intelligence (AI), also successfully predicts the severity of autism symptoms in individual patients. With further honing, the algorithm could lead to earlier diagnoses, more targeted therapies, and broadened understanding of autism’s origins in the brain.

The algorithm pores over data gathered through functional magnetic resonance imaging (fMRI) scans. These scans capture patterns of neural activity throughout the brain. Scientists have long searched for biomarkers via fMRI scans. Yet studies to date with small populations have reported conflicting results, stemming from natural variability in patients’ brains and confounded further by differences in fMRI machines and testing methods. In deriving their image-recognition algorithms, the researchers sought to make the artificial intelligence explainable (or XAI), or understandable to human researchers.

By mapping this activity over time in the brain’s many regions, the algorithm generates neural activity “fingerprints.” Although unique for each individual just like real fingerprints, the brain fingerprints nevertheless share similar features, allowing them to be sorted and classified. In a new study, the algorithm assessed brain scans from a sample of approximately 1,100 patients. With 82% accuracy, the algorithm selected out a group of patients whom human clinicians had diagnosed with autism. The XAI algorithm alit upon three brain regions exhibiting significant differences in interconnectivity in a groupable portion of the dataset. Lending credibility to the XAI algorithm’s findings, those three brain regions have been previously implicated in autism pathology.

While the XAI algorithm performed admirably at this early stage of development, the researchers will need to improve its accuracy further still to raise brain fingerprinting to the level of a definitive biomarker. The researchers intend to explore the algorithm's efficacy in sibling studies, where one sibling has autism and the other does not, to hone the ability to detect fine-tuned, yet critical differences between potentially very similar brains. The researchers envision brain fingerprinting being used to assess the brains of very young children, perhaps as early as six months or a year old, who are at high risk of developing autism. Earlier diagnosis is critical in achieving better outcomes, with therapies proving more effective when introduced while patients are still toddler-aged versus later in childhood

“Although autism is one of the most common neurodevelopmental disorders, there is so much about it that we still don’t understand,” said lead author Kaustubh Supekar, a Stanford clinical assistant professor of psychiatry and behavioral sciences and Stanford HAI affiliate faculty. “In this study, we’ve shown that our AI-driven brain ‘fingerprinting’ model could potentially be a powerful new tool in advancing diagnosis and treatment.”

“We need to create objective biomarkers for autism,” added Supekar, “and brain fingerprints get us one step closer. We hope that the approach demonstrated in our study could diagnose autism during the window of opportunity when interventions are maximally most effective.”

Related Links:
Stanford University 

New
Ultrasound Needle Guidance System
SonoSite L25
Biopsy Software
Affirm® Contrast
New
Mammography System (Analog)
MAM VENUS
Portable Color Doppler Ultrasound Scanner
DCU10

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.